“SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY: Long-lasting disease remission with third line therapy with gilteritinib”, Mediterr J Hematol Infect Dis, vol. 16, no. 1, p. e2024079, Oct. 2024, doi: 10.4084/MJHID.2024.079.